Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Avricore Health (AVCRF) Short-term Investments (2016 - 2022)

Historic Short-term Investments for Avricore Health (AVCRF) over the last 8 years, with Q3 2022 value amounting to $237691.3.

  • Avricore Health's Short-term Investments fell 348.22% to $237691.3 in Q3 2022 from the same period last year, while for Sep 2022 it was $237691.3, marking a year-over-year decrease of 348.22%. This contributed to the annual value of $247366.2 for FY2021, which is 321377.02% up from last year.
  • According to the latest figures from Q3 2022, Avricore Health's Short-term Investments is $237691.3, which was down 348.22% from $243145.6 recorded in Q2 2022.
  • Avricore Health's 5-year Short-term Investments high stood at $252193.4 for Q2 2021, and its period low was $7212.0 during Q2 2020.
  • For the 5-year period, Avricore Health's Short-term Investments averaged around $110813.7, with its median value being $12836.8 (2018).
  • As far as peak fluctuations go, Avricore Health's Short-term Investments crashed by 9918.9% in 2018, and later surged by 339683.93% in 2021.
  • Avricore Health's Short-term Investments (Quarter) stood at $12840.1 in 2018, then decreased by 1.35% to $12667.0 in 2019, then plummeted by 39.44% to $7670.5 in 2020, then surged by 3106.22% to $245934.2 in 2021, then fell by 3.35% to $237691.3 in 2022.
  • Its Short-term Investments was $237691.3 in Q3 2022, compared to $243145.6 in Q2 2022 and $244737.3 in Q1 2022.